Related Articles Terahertz absorption spectra of original and generic ceftazidime. Anal Sci. 2009 Dec;25(12):1483-5 Authors: Kawase M, Saito T, Ogawa M, Uejima H, Hatsuda Y, Kawanishi S, Hirotani Y, Myotoku M, Ikeda K, Takano K, Hangyo M, Yamamoto K, Tani M The absorption spectra of ceftazidime and its generic versions (Modacin, Mosyl, and Mobenzocin) have been measured by terahertz time domain spectroscopy (THz-TDS). Differences in the THz absorption were observed between the original and generic versions. The results show small, but significant differences in the states of ceftazidime hydrate between the original and generic versions. THz-TDS can be used to evaluate the stability of medicines as well as to control their quality. PMID: 20009339 [PubMed - indexed for MEDLINE]
Continue reading here:
Terahertz absorption spectra of original and generic ceftazidime.
Related Articles Financial Times Global Pharmaceutical & Biotechnology Conference 2009. IDrugs. 2010 Jan;13(1):26-9 Authors: Scattereggia J The Financial Times Global Pharmaceutical & Biotechnology conference, held in London, included topics covering the current and future challenges confronting the pharma and biotech industry, and presented possible solutions to those challenges. This conference report highlights selected presentations on the industry challenges for big pharma companies, diversification as a solution to industry problems, overcoming challenges with collaborations and M&As, and the role of emerging markets in the pharma industry. Other subjects discussed included the expected impact of personalized medicine on the industry, the entry of big pharma into the generics market and the problems that are confronting the small pharma and biotech industry. PMID: 20024844 [PubMed - indexed for MEDLINE]
Read the original here:
Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
